
### [NCIT:C40076](http://purl.obolibrary.org/obo/NCIT_C40076)
**Label:** Ovarian Clear Cell Tumor

**Subclasses:** [NCIT:C40078](http://purl.obolibrary.org/obo/NCIT_C40078) (Ovarian Clear Cell Adenocarcinoma), [NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma), [NCIT:C40077](http://purl.obolibrary.org/obo/NCIT_C40077) (Malignant Ovarian Clear Cell Tumor), [NCIT:C40085](http://purl.obolibrary.org/obo/NCIT_C40085) (Ovarian Clear Cell Adenofibroma), [NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma), [NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma), [NCIT:C40084](http://purl.obolibrary.org/obo/NCIT_C40084) (Benign Ovarian Clear Cell Tumor), [NCIT:C40081](http://purl.obolibrary.org/obo/NCIT_C40081) (Borderline Ovarian Clear Cell Adenofibroma), [NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma), [NCIT:C40080](http://purl.obolibrary.org/obo/NCIT_C40080) (Borderline Ovarian Clear Cell Tumor), [NCIT:C7980](http://purl.obolibrary.org/obo/NCIT_C7980) (Ovarian Clear Cell Cystadenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.49%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38996](http://purl.obolibrary.org/obo/NCIT_C38996) (ATM Signaling Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 43.69%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 43.69%


